SCHEMBL31366709

SCHEMBL31366709

NC(=O)OC1CCCC1.O=C(O)NC1CCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 8/20 0.56
SMN1; SMN2 Q16637 4/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP3A4 P08684 1/20 0.42
EPHX2 P34913 1/20 0.42
HTT P42858 1/20 0.38
GAA P10253 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
MMP2 P08253 2/20 0.37
CA9 Q16790 2/20 0.37
MMP1 P03956 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MAPK10 P53779 1/20 0.37
MMP8 P22894 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30035740 0.98 EPHX1 (0.59) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL30034737 0.96 EPHX1 (0.52) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5263260 0.89 EPHX1 (0.41) EPHX1SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL5263263 0.89 EPHX1 (0.41) EPHX1SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL112091 0.82
SCHEMBL23573302 0.81 EPHX1 (0.57) EPHX1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL113152 0.80 EPHX1 (0.50) EPHX1HTTCA12CA1CA2
SCHEMBL1416705 0.80 EPHX1 (0.50) EPHX1HTTCA12CA1CA2
SCHEMBL28110614 0.80 EPHX1 (0.50) EPHX1HTTCA12CA1CA2
SCHEMBL1416449 0.80 EPHX1 (0.50) EPHX1HTTCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114945572-B HBF pharmacological inducing compounds for the treatment of sickle cell anemia and beta-thalassemia 周美吟 2025-01-28 CN disclosed